Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by inviolablspiriton Oct 22, 2024 3:49pm

60 Views

Post# 36277322

Pharmala - Europe

I know there is lots of speculation regarding Europe, as Nick recently returned from a conference there. I'm sure there will be more to come in the future, however I think some investors have forgetten that Pharmala has already sent product to the UK so in a way we are already there to an extent.

<< Previous

Bullboard Posts

Next >>

A glide path to profitable gold production